Research Article

Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of Chronic Kidney Disease: Implications for Developing Countries

Table 2

Mean haemoglobin at the end of the trials.

Study or subgroupAndrogenErythropoietinMean difference Mean difference
MeanSDTotalMeanSDTotalWeightIV, random, 95% CI IV, random, 95% CI

Aggarwal et al. [6]7.740.61158.70.61528.7%−0.96 [−1.39, −0.53]580437.fig.003
Gascon et al. [5]111.41410.60.91921.9%0.40 [−0.44, 1.24]
Navarro et al. [4]11.80.41311.70.61429.4%0.10 [−0.28, 0.48]
Singh et al. [7]12.831.041212.61.331220.0%0.23 [−0.73, 1.19]
Total (95% CI)5460100.0%−0.11 [−0.80, 0.58]
Heterogeneity: tau2 = 0.38; chi2 = 16.83; df = 3 (P = 0.0008); = 82%.
Test for overall effect: Z = 0.32 (P = 0.75).